4/26
08:11 am
rytm
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Medium
Report
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
4/24
04:01 pm
rytm
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Medium
Report
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
4/18
07:55 pm
rytm
Cramer's Lighting Round: Sell Aspen Aerogels [CNBC]
Low
Report
Cramer's Lighting Round: Sell Aspen Aerogels [CNBC]
4/18
09:00 am
rytm
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Wells Fargo & Company from $53.00 to $52.00. They now have an "overweight" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Wells Fargo & Company from $53.00 to $52.00. They now have an "overweight" rating on the stock.
4/16
04:01 pm
rytm
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Low
Report
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
4/14
09:19 am
rytm
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) [Yahoo! Finance]
Low
Report
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) [Yahoo! Finance]
4/10
08:05 am
rytm
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Medium
Report
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
4/1
08:19 am
rytm
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing [Yahoo! Finance]
Low
Report
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing [Yahoo! Finance]
4/1
08:00 am
rytm
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
Low
Report
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
3/25
08:00 am
rytm
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
Low
Report
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
3/11
04:01 pm
rytm
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Low
Report
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
3/6
04:01 pm
rytm
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Low
Report
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
3/3
07:58 am
rytm
Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint [Yahoo! Finance]
2/23
12:21 pm
rytm
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
12:31 pm
rytm
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Medium
Report
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
2/22
07:44 am
rytm
Rhythm Pharmaceuticals Inc (RYTM) Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals Inc (RYTM) Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
2/22
07:06 am
rytm
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update [Yahoo! Finance]
2/22
07:02 am
rytm
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan [Yahoo! Finance]
2/22
07:01 am
rytm
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
Medium
Report
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
2/22
07:00 am
rytm
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
Medium
Report
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
2/15
11:53 am
rytm
Rhythm Pharmaceuticals, Inc. (RYTM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
Rhythm Pharmaceuticals, Inc. (RYTM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
2/14
02:51 am
rytm
EVP Yann Mazabraud Sells 2,551 Shares of Rhythm Pharmaceuticals Inc [Yahoo! Finance]
Low
Report
EVP Yann Mazabraud Sells 2,551 Shares of Rhythm Pharmaceuticals Inc [Yahoo! Finance]
2/13
03:12 pm
rytm
PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals [Yahoo! Finance]
Low
Report
PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals [Yahoo! Finance]
2/8
04:01 pm
rytm
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Medium
Report
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
2/7
08:00 am
rytm
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
Low
Report
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome